

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 6.16437143 |
| 2 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 6.16437143 |
| 3 | modulation by symbiont of host immune response (GO:0052553) | 6.16437143 |
| 4 | positive regulation by symbiont of host defense response (GO:0052509) | 6.16437143 |
| 5 | modulation by symbiont of host defense response (GO:0052031) | 6.16437143 |
| 6 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 6.16437143 |
| 7 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.00826885 |
| 8 | negative regulation of cell killing (GO:0031342) | 5.51516319 |
| 9 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.51516319 |
| 10 | macrophage activation involved in immune response (GO:0002281) | 5.36354518 |
| 11 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.34825095 |
| 12 | neutrophil activation involved in immune response (GO:0002283) | 5.15289061 |
| 13 | detection of molecule of bacterial origin (GO:0032490) | 5.10669117 |
| 14 | detection of other organism (GO:0098543) | 4.96112809 |
| 15 | response to peptidoglycan (GO:0032494) | 4.87970903 |
| 16 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.81975929 |
| 17 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.79209120 |
| 18 | cellular extravasation (GO:0045123) | 4.72279898 |
| 19 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.68500287 |
| 20 | phospholipid efflux (GO:0033700) | 4.63348565 |
| 21 | detection of external biotic stimulus (GO:0098581) | 4.55428980 |
| 22 | detection of bacterium (GO:0016045) | 4.54832475 |
| 23 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.38256224 |
| 24 | leukocyte migration involved in inflammatory response (GO:0002523) | 4.35077704 |
| 25 | regulation of triglyceride catabolic process (GO:0010896) | 4.32557578 |
| 26 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.30303028 |
| 27 | negative regulation of interleukin-12 production (GO:0032695) | 4.29107740 |
| 28 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.26410298 |
| 29 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.20761070 |
| 30 | response to host immune response (GO:0052572) | 4.20761070 |
| 31 | microglial cell activation (GO:0001774) | 4.16409192 |
| 32 | neutrophil activation (GO:0042119) | 4.14056592 |
| 33 | detection of biotic stimulus (GO:0009595) | 4.01358965 |
| 34 | macrophage activation (GO:0042116) | 3.95203707 |
| 35 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.93880605 |
| 36 | response to host (GO:0075136) | 3.88928489 |
| 37 | response to host defenses (GO:0052200) | 3.88928489 |
| 38 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.88928489 |
| 39 | regulation of gamma-delta T cell activation (GO:0046643) | 3.87910103 |
| 40 | leukocyte aggregation (GO:0070486) | 3.84151530 |
| 41 | respiratory burst (GO:0045730) | 3.82123428 |
| 42 | neutrophil mediated immunity (GO:0002446) | 3.78350341 |
| 43 | granulocyte activation (GO:0036230) | 3.75825659 |
| 44 | myeloid cell activation involved in immune response (GO:0002275) | 3.74499796 |
| 45 | response to interleukin-15 (GO:0070672) | 3.62182091 |
| 46 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.56157225 |
| 47 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.54614083 |
| 48 | cellular response to type I interferon (GO:0071357) | 3.54484849 |
| 49 | type I interferon signaling pathway (GO:0060337) | 3.54484849 |
| 50 | immunoglobulin mediated immune response (GO:0016064) | 3.53967114 |
| 51 | response to type I interferon (GO:0034340) | 3.51790787 |
| 52 | plasma lipoprotein particle assembly (GO:0034377) | 3.50321886 |
| 53 | high-density lipoprotein particle remodeling (GO:0034375) | 3.47312275 |
| 54 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.43274426 |
| 55 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.43088055 |
| 56 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.41539094 |
| 57 | regulation of mast cell degranulation (GO:0043304) | 3.38314906 |
| 58 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.35451845 |
| 59 | cellular response to interleukin-15 (GO:0071350) | 3.35249578 |
| 60 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 3.27953802 |
| 61 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.25511380 |
| 62 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.25242421 |
| 63 | negative regulation of T cell mediated immunity (GO:0002710) | 3.21921320 |
| 64 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.21481090 |
| 65 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.21054088 |
| 66 | myeloid leukocyte mediated immunity (GO:0002444) | 3.18406398 |
| 67 | germinal center formation (GO:0002467) | 3.17319979 |
| 68 | positive regulation of mast cell activation (GO:0033005) | 3.15478733 |
| 69 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.15451705 |
| 70 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.12389504 |
| 71 | protein-lipid complex assembly (GO:0065005) | 3.11978063 |
| 72 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.11974333 |
| 73 | response to muramyl dipeptide (GO:0032495) | 3.10803615 |
| 74 | positive regulation of interferon-alpha production (GO:0032727) | 3.09332494 |
| 75 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.04500920 |
| 76 | regulation of mast cell activation (GO:0033003) | 3.02530666 |
| 77 | leukocyte degranulation (GO:0043299) | 3.02187361 |
| 78 | defense response to protozoan (GO:0042832) | 2.97945356 |
| 79 | neutrophil chemotaxis (GO:0030593) | 2.97524164 |
| 80 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.95693919 |
| 81 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.95680433 |
| 82 | regulation of leukocyte degranulation (GO:0043300) | 2.94437045 |
| 83 | reverse cholesterol transport (GO:0043691) | 2.93919887 |
| 84 | response to interferon-alpha (GO:0035455) | 2.93430849 |
| 85 | regulation of interferon-alpha production (GO:0032647) | 2.92791221 |
| 86 | B cell receptor signaling pathway (GO:0050853) | 2.91733036 |
| 87 | neutrophil migration (GO:1990266) | 2.89679593 |
| 88 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.88705298 |
| 89 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.88233737 |
| 90 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.87887687 |
| 91 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.87887687 |
| 92 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.87478397 |
| 93 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.86786369 |
| 94 | I-kappaB phosphorylation (GO:0007252) | 2.86438986 |
| 95 | negative regulation of interleukin-1 production (GO:0032692) | 2.86005874 |
| 96 | regulation of T cell tolerance induction (GO:0002664) | 2.84373092 |
| 97 | regulation of tolerance induction (GO:0002643) | 2.84233325 |
| 98 | dendritic cell migration (GO:0036336) | 2.78841283 |
| 99 | dendritic cell chemotaxis (GO:0002407) | 2.78051908 |
| 100 | myeloid leukocyte activation (GO:0002274) | 2.75625958 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.60934493 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.24557317 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.16282341 |
| 4 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.65381098 |
| 5 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.44085610 |
| 6 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.36287128 |
| 7 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.26714633 |
| 8 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.21460021 |
| 9 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.17138233 |
| 10 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.80966848 |
| 11 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.67690682 |
| 12 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.65692036 |
| 13 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.65534325 |
| 14 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.62917360 |
| 15 | SPI1_23127762_ChIP-Seq_K562_Human | 2.57250123 |
| 16 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.46765824 |
| 17 | GATA1_22025678_ChIP-Seq_K562_Human | 2.45499446 |
| 18 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.42392733 |
| 19 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.40758164 |
| 20 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.37370569 |
| 21 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.34560818 |
| 22 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.23811862 |
| 23 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.18065298 |
| 24 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.16158660 |
| 25 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.13324831 |
| 26 | MYB_26560356_Chip-Seq_TH2_Human | 2.10907549 |
| 27 | VDR_24787735_ChIP-Seq_THP-1_Human | 2.03452392 |
| 28 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.03341852 |
| 29 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.01527134 |
| 30 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.97611749 |
| 31 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.97455286 |
| 32 | MAF_26560356_Chip-Seq_TH1_Human | 1.91591758 |
| 33 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.89058325 |
| 34 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.86513694 |
| 35 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.82194024 |
| 36 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.81412910 |
| 37 | MYB_26560356_Chip-Seq_TH1_Human | 1.72439198 |
| 38 | UTX_26944678_Chip-Seq_JUKART_Human | 1.71407384 |
| 39 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.64095585 |
| 40 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.63335880 |
| 41 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.61299888 |
| 42 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.58454522 |
| 43 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.52491985 |
| 44 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.52442132 |
| 45 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.52234385 |
| 46 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.48452074 |
| 47 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.48418038 |
| 48 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.47798175 |
| 49 | MAF_26560356_Chip-Seq_TH2_Human | 1.39721646 |
| 50 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.39040441 |
| 51 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.38980414 |
| 52 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.37639853 |
| 53 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.37272623 |
| 54 | GATA3_26560356_Chip-Seq_TH2_Human | 1.34806650 |
| 55 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.32724469 |
| 56 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.32547261 |
| 57 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.31988414 |
| 58 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.31685303 |
| 59 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.29445347 |
| 60 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.18562335 |
| 61 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.17968379 |
| 62 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.14992802 |
| 63 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.13327424 |
| 64 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.12703166 |
| 65 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.12389602 |
| 66 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.11977903 |
| 67 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.11906387 |
| 68 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.11804603 |
| 69 | MYC_22102868_ChIP-Seq_BL_Human | 1.11742768 |
| 70 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.10965265 |
| 71 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.07441437 |
| 72 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.06392330 |
| 73 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.03635797 |
| 74 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.03560667 |
| 75 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.00235629 |
| 76 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.00175860 |
| 77 | GATA1_19941826_ChIP-Seq_K562_Human | 0.97855241 |
| 78 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.92947150 |
| 79 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.91200819 |
| 80 | GATA2_19941826_ChIP-Seq_K562_Human | 0.88690687 |
| 81 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.87569769 |
| 82 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.87540425 |
| 83 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.87168416 |
| 84 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.87072384 |
| 85 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.86905840 |
| 86 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.86676736 |
| 87 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.86158692 |
| 88 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.83245551 |
| 89 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.82744723 |
| 90 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.81073883 |
| 91 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.81005004 |
| 92 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.78353246 |
| 93 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.77225436 |
| 94 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.76881135 |
| 95 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.75989799 |
| 96 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.75767864 |
| 97 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.75282941 |
| 98 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.74407786 |
| 99 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.73991531 |
| 100 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.73794234 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003724_increased_susceptibility_to | 5.43433467 |
| 2 | MP0009840_abnormal_foam_cell | 4.29338860 |
| 3 | MP0003436_decreased_susceptibility_to | 4.09020222 |
| 4 | MP0003303_peritoneal_inflammation | 3.80007981 |
| 5 | MP0001835_abnormal_antigen_presentation | 3.52360688 |
| 6 | MP0002419_abnormal_innate_immunity | 3.10359364 |
| 7 | MP0003191_abnormal_cellular_cholesterol | 2.79905539 |
| 8 | MP0006082_CNS_inflammation | 2.76822428 |
| 9 | MP0005025_abnormal_response_to | 2.69390858 |
| 10 | MP0009785_altered_susceptibility_to | 2.67055336 |
| 11 | MP0001800_abnormal_humoral_immune | 2.58764392 |
| 12 | MP0005000_abnormal_immune_tolerance | 2.49949174 |
| 13 | MP0001790_abnormal_immune_system | 2.47584244 |
| 14 | MP0005387_immune_system_phenotype | 2.47584244 |
| 15 | MP0000685_abnormal_immune_system | 2.42117795 |
| 16 | MP0002723_abnormal_immune_serum | 2.37102990 |
| 17 | MP0005671_abnormal_response_to | 2.29223171 |
| 18 | MP0002452_abnormal_antigen_presenting | 2.23046958 |
| 19 | MP0003300_gastrointestinal_ulcer | 2.19823365 |
| 20 | MP0002420_abnormal_adaptive_immunity | 2.19540393 |
| 21 | MP0001533_abnormal_skeleton_physiology | 2.18109445 |
| 22 | MP0001819_abnormal_immune_cell | 2.17502083 |
| 23 | MP0002148_abnormal_hypersensitivity_rea | 2.01014891 |
| 24 | MP0003045_fibrosis | 1.96287637 |
| 25 | MP0005464_abnormal_platelet_physiology | 1.90776664 |
| 26 | MP0003828_pulmonary_edema | 1.86385613 |
| 27 | MP0002132_abnormal_respiratory_system | 1.78814024 |
| 28 | MP0008260_abnormal_autophagy | 1.78020988 |
| 29 | MP0010155_abnormal_intestine_physiology | 1.77837334 |
| 30 | MP0002405_respiratory_system_inflammati | 1.72692674 |
| 31 | MP0000716_abnormal_immune_system | 1.64487184 |
| 32 | MP0004883_abnormal_blood_vessel | 1.63152636 |
| 33 | MP0001845_abnormal_inflammatory_respons | 1.61000081 |
| 34 | MP0009278_abnormal_bone_marrow | 1.59035986 |
| 35 | MP0005164_abnormal_response_to | 1.57987352 |
| 36 | MP0005360_urolithiasis | 1.57101135 |
| 37 | MP0003690_abnormal_glial_cell | 1.54412973 |
| 38 | MP0009764_decreased_sensitivity_to | 1.51611773 |
| 39 | MP0008469_abnormal_protein_level | 1.50894943 |
| 40 | MP0002398_abnormal_bone_marrow | 1.50750983 |
| 41 | MP0005451_abnormal_body_composition | 1.46579548 |
| 42 | MP0005377_hearing/vestibular/ear_phenot | 1.46405402 |
| 43 | MP0003878_abnormal_ear_physiology | 1.46405402 |
| 44 | MP0003866_abnormal_defecation | 1.45044174 |
| 45 | MP0003183_abnormal_peptide_metabolism | 1.43865711 |
| 46 | MP0003172_abnormal_lysosome_physiology | 1.42199992 |
| 47 | MP0003763_abnormal_thymus_physiology | 1.38334784 |
| 48 | MP0004510_myositis | 1.36352142 |
| 49 | MP0002277_abnormal_respiratory_mucosa | 1.35350085 |
| 50 | MP0004947_skin_inflammation | 1.33574334 |
| 51 | MP0003950_abnormal_plasma_membrane | 1.33139852 |
| 52 | MP0000465_gastrointestinal_hemorrhage | 1.29815903 |
| 53 | MP0004381_abnormal_hair_follicle | 1.27706870 |
| 54 | MP0004145_abnormal_muscle_electrophysio | 1.27547812 |
| 55 | MP0001851_eye_inflammation | 1.26781002 |
| 56 | MP0000689_abnormal_spleen_morphology | 1.25640487 |
| 57 | MP0002429_abnormal_blood_cell | 1.24281575 |
| 58 | MP0002722_abnormal_immune_system | 1.23943255 |
| 59 | MP0005397_hematopoietic_system_phenotyp | 1.22015441 |
| 60 | MP0001545_abnormal_hematopoietic_system | 1.22015441 |
| 61 | MP0003075_altered_response_to | 1.20170506 |
| 62 | MP0002998_abnormal_bone_remodeling | 1.19872223 |
| 63 | MP0002396_abnormal_hematopoietic_system | 1.17359032 |
| 64 | MP0005310_abnormal_salivary_gland | 1.15850850 |
| 65 | MP0002254_reproductive_system_inflammat | 1.15258017 |
| 66 | MP0005058_abnormal_lysosome_morphology | 1.13346859 |
| 67 | MP0000858_altered_metastatic_potential | 1.09837569 |
| 68 | MP0008004_abnormal_stomach_pH | 1.08460805 |
| 69 | MP0009333_abnormal_splenocyte_physiolog | 1.07447667 |
| 70 | MP0005166_decreased_susceptibility_to | 0.98725667 |
| 71 | MP0001958_emphysema | 0.97879536 |
| 72 | MP0000343_altered_response_to | 0.95588243 |
| 73 | MP0000604_amyloidosis | 0.94318127 |
| 74 | MP0001663_abnormal_digestive_system | 0.92891929 |
| 75 | MP0000703_abnormal_thymus_morphology | 0.90303960 |
| 76 | MP0000249_abnormal_blood_vessel | 0.85949874 |
| 77 | MP0005381_digestive/alimentary_phenotyp | 0.82545532 |
| 78 | MP0002168_other_aberrant_phenotype | 0.81650328 |
| 79 | MP0005390_skeleton_phenotype | 0.80489567 |
| 80 | MP0009763_increased_sensitivity_to | 0.72812930 |
| 81 | MP0002166_altered_tumor_susceptibility | 0.72259937 |
| 82 | MP0008874_decreased_physiological_sensi | 0.70272486 |
| 83 | MP0003656_abnormal_erythrocyte_physiolo | 0.69603225 |
| 84 | MP0005409_darkened_coat_color | 0.65662538 |
| 85 | MP0000015_abnormal_ear_pigmentation | 0.65428652 |
| 86 | MP0003448_altered_tumor_morphology | 0.65057726 |
| 87 | MP0000920_abnormal_myelination | 0.64787474 |
| 88 | MP0000569_abnormal_digit_pigmentation | 0.63746771 |
| 89 | MP0005319_abnormal_enzyme/_coenzyme | 0.61657589 |
| 90 | MP0000767_abnormal_smooth_muscle | 0.60180445 |
| 91 | MP0004484_altered_response_of | 0.60133173 |
| 92 | MP0001986_abnormal_taste_sensitivity | 0.59439917 |
| 93 | MP0005388_respiratory_system_phenotype | 0.57121673 |
| 94 | MP0002133_abnormal_respiratory_system | 0.57121673 |
| 95 | MP0010329_abnormal_lipoprotein_level | 0.57048501 |
| 96 | MP0004130_abnormal_muscle_cell | 0.55373734 |
| 97 | MP0005174_abnormal_tail_pigmentation | 0.55368780 |
| 98 | MP0004808_abnormal_hematopoietic_stem | 0.54947036 |
| 99 | MP0003795_abnormal_bone_structure | 0.54829637 |
| 100 | MP0002332_abnormal_exercise_endurance | 0.54056078 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of macrophages (HP:0004311) | 6.28955951 |
| 2 | Eczematoid dermatitis (HP:0000976) | 6.28553792 |
| 3 | Recurrent abscess formation (HP:0002722) | 5.74469656 |
| 4 | Myositis (HP:0100614) | 5.72418831 |
| 5 | Orchitis (HP:0100796) | 5.67467280 |
| 6 | Recurrent bacterial skin infections (HP:0005406) | 5.61001713 |
| 7 | Malnutrition (HP:0004395) | 5.46494264 |
| 8 | Retrobulbar optic neuritis (HP:0100654) | 5.37952285 |
| 9 | Optic neuritis (HP:0100653) | 5.37952285 |
| 10 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.89637918 |
| 11 | Stomatitis (HP:0010280) | 4.51165644 |
| 12 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.17297083 |
| 13 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.14917458 |
| 14 | Recurrent fungal infections (HP:0002841) | 4.07819940 |
| 15 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.96737914 |
| 16 | Recurrent cutaneous fungal infections (HP:0011370) | 3.96737914 |
| 17 | Mediastinal lymphadenopathy (HP:0100721) | 3.91951740 |
| 18 | Gastrointestinal infarctions (HP:0005244) | 3.87098298 |
| 19 | Recurrent skin infections (HP:0001581) | 3.86993620 |
| 20 | Keratoconjunctivitis sicca (HP:0001097) | 3.80053425 |
| 21 | Hypochromic microcytic anemia (HP:0004840) | 3.78770777 |
| 22 | Gingival bleeding (HP:0000225) | 3.68865861 |
| 23 | Spontaneous hematomas (HP:0007420) | 3.66762833 |
| 24 | Chronic obstructive pulmonary disease (HP:0006510) | 3.61233031 |
| 25 | Obstructive lung disease (HP:0006536) | 3.61233031 |
| 26 | Meningitis (HP:0001287) | 3.53535666 |
| 27 | Keratoconjunctivitis (HP:0001096) | 3.51408416 |
| 28 | Amyloidosis (HP:0011034) | 3.48504186 |
| 29 | Encephalitis (HP:0002383) | 3.48413405 |
| 30 | Gingivitis (HP:0000230) | 3.42717588 |
| 31 | Increased IgE level (HP:0003212) | 3.26147256 |
| 32 | Hypobetalipoproteinemia (HP:0003563) | 3.24487306 |
| 33 | Vasculitis (HP:0002633) | 3.14732917 |
| 34 | Peritonitis (HP:0002586) | 3.13741237 |
| 35 | Urticaria (HP:0001025) | 3.10670465 |
| 36 | Episodic fever (HP:0001954) | 3.09908932 |
| 37 | Hyperlipoproteinemia (HP:0010980) | 3.09062740 |
| 38 | Hypochromic anemia (HP:0001931) | 2.97128962 |
| 39 | Prolonged bleeding time (HP:0003010) | 2.92870709 |
| 40 | Hemoptysis (HP:0002105) | 2.90714674 |
| 41 | Chest pain (HP:0100749) | 2.87584245 |
| 42 | Epistaxis (HP:0000421) | 2.86815450 |
| 43 | Arterial thrombosis (HP:0004420) | 2.81327898 |
| 44 | Pulmonary infiltrates (HP:0002113) | 2.80298136 |
| 45 | T lymphocytopenia (HP:0005403) | 2.77513178 |
| 46 | Abnormality of T cell number (HP:0011839) | 2.68060309 |
| 47 | Pulmonary embolism (HP:0002204) | 2.62539287 |
| 48 | Anorexia (HP:0002039) | 2.60109219 |
| 49 | Recurrent viral infections (HP:0004429) | 2.59271134 |
| 50 | Cellulitis (HP:0100658) | 2.57712982 |
| 51 | Leukocytosis (HP:0001974) | 2.44032319 |
| 52 | Inflammation of the large intestine (HP:0002037) | 2.40314638 |
| 53 | Sepsis (HP:0100806) | 2.39780218 |
| 54 | Petechiae (HP:0000967) | 2.37657391 |
| 55 | Increased serum ferritin (HP:0003281) | 2.35760817 |
| 56 | Abnormal platelet volume (HP:0011876) | 2.30283798 |
| 57 | Osteomyelitis (HP:0002754) | 2.28431265 |
| 58 | Loss of speech (HP:0002371) | 2.27132384 |
| 59 | Aortic aneurysm (HP:0004942) | 2.25413848 |
| 60 | Gangrene (HP:0100758) | 2.25158243 |
| 61 | Gastrointestinal inflammation (HP:0004386) | 2.24655365 |
| 62 | Abnormality of the peritoneum (HP:0002585) | 2.24377616 |
| 63 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.22229519 |
| 64 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.20904998 |
| 65 | Abnormality of T cells (HP:0002843) | 2.20187425 |
| 66 | Microcytic anemia (HP:0001935) | 2.19515479 |
| 67 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.17153819 |
| 68 | Abnormality of iron homeostasis (HP:0011031) | 2.16839857 |
| 69 | Joint hemorrhage (HP:0005261) | 2.15852849 |
| 70 | Abnormality of the pleura (HP:0002103) | 2.10083627 |
| 71 | Panhypogammaglobulinemia (HP:0003139) | 2.09581659 |
| 72 | Increased IgM level (HP:0003496) | 2.04253501 |
| 73 | Cheilitis (HP:0100825) | 2.02608068 |
| 74 | Abnormality of T cell physiology (HP:0011840) | 2.02130551 |
| 75 | Abnormality of the common coagulation pathway (HP:0010990) | 2.00835828 |
| 76 | Abnormality of the pericardium (HP:0001697) | 2.00245296 |
| 77 | Vertigo (HP:0002321) | 1.98700559 |
| 78 | Chronic otitis media (HP:0000389) | 1.95968649 |
| 79 | Abnormality of the endocardium (HP:0004306) | 1.95854379 |
| 80 | Keratitis (HP:0000491) | 1.95204262 |
| 81 | Colitis (HP:0002583) | 1.93387229 |
| 82 | Neoplasm of the heart (HP:0100544) | 1.93277642 |
| 83 | Vacuolated lymphocytes (HP:0001922) | 1.93207858 |
| 84 | Pustule (HP:0200039) | 1.92281664 |
| 85 | Gastrointestinal dysmotility (HP:0002579) | 1.91622452 |
| 86 | Granulocytopenia (HP:0001913) | 1.91520441 |
| 87 | Polyneuropathy (HP:0001271) | 1.90824866 |
| 88 | Acne (HP:0001061) | 1.87927262 |
| 89 | Thrombophlebitis (HP:0004418) | 1.87322511 |
| 90 | Dysostosis multiplex (HP:0000943) | 1.85990416 |
| 91 | Glomerulopathy (HP:0100820) | 1.85958131 |
| 92 | Tetany (HP:0001281) | 1.85007476 |
| 93 | Menorrhagia (HP:0000132) | 1.84740947 |
| 94 | Slow saccadic eye movements (HP:0000514) | 1.84604098 |
| 95 | Hypergammaglobulinemia (HP:0010702) | 1.83869914 |
| 96 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.83095272 |
| 97 | Increased cerebral lipofuscin (HP:0011813) | 1.82064863 |
| 98 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.80495965 |
| 99 | Joint swelling (HP:0001386) | 1.80207666 |
| 100 | Hepatosplenomegaly (HP:0001433) | 1.77997530 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 4.55615541 |
| 2 | PIK3CG | 4.07739512 |
| 3 | IRAK4 | 3.25041333 |
| 4 | BLK | 3.03079868 |
| 5 | TYK2 | 2.84453117 |
| 6 | MAP2K3 | 2.80401350 |
| 7 | MAP4K1 | 2.64385828 |
| 8 | CSK | 2.53721608 |
| 9 | MUSK | 2.53457716 |
| 10 | DMPK | 2.48749681 |
| 11 | ERN1 | 2.42585942 |
| 12 | EPHB1 | 2.31449500 |
| 13 | TNK2 | 2.15906580 |
| 14 | TESK2 | 2.01000508 |
| 15 | FES | 1.94406046 |
| 16 | GRK6 | 1.91558259 |
| 17 | ZAP70 | 1.84776240 |
| 18 | TTN | 1.77071283 |
| 19 | PRPF4B | 1.60912132 |
| 20 | FGR | 1.57886989 |
| 21 | MAP3K3 | 1.56487185 |
| 22 | HCK | 1.54019061 |
| 23 | JAK3 | 1.52917173 |
| 24 | TAOK1 | 1.52777582 |
| 25 | TXK | 1.52595249 |
| 26 | JAK1 | 1.44978128 |
| 27 | BTK | 1.39894989 |
| 28 | JAK2 | 1.37894088 |
| 29 | SYK | 1.36823173 |
| 30 | IKBKE | 1.35202455 |
| 31 | KSR2 | 1.30534184 |
| 32 | MAP3K14 | 1.30278628 |
| 33 | IRAK2 | 1.26595650 |
| 34 | YES1 | 1.22658482 |
| 35 | IRAK1 | 1.18835916 |
| 36 | MYLK | 1.17948130 |
| 37 | TBK1 | 1.15516574 |
| 38 | LYN | 1.13904821 |
| 39 | MAP3K11 | 1.13340750 |
| 40 | CDC42BPA | 1.11190846 |
| 41 | MAP3K13 | 1.10243103 |
| 42 | MARK3 | 1.08951576 |
| 43 | MAP3K1 | 1.04784232 |
| 44 | CSF1R | 1.03187677 |
| 45 | LCK | 1.03049875 |
| 46 | MATK | 0.95531401 |
| 47 | KIT | 0.94731789 |
| 48 | MAP3K2 | 0.93235484 |
| 49 | NLK | 0.90910986 |
| 50 | PDK1 | 0.85700844 |
| 51 | MARK2 | 0.82628662 |
| 52 | SIK3 | 0.81568508 |
| 53 | PDPK1 | 0.81510755 |
| 54 | MAP3K7 | 0.80163036 |
| 55 | PTK2B | 0.77808251 |
| 56 | MAP3K6 | 0.77624923 |
| 57 | CDK19 | 0.77057391 |
| 58 | PTK6 | 0.76669950 |
| 59 | FGFR3 | 0.74878536 |
| 60 | STK10 | 0.74804279 |
| 61 | TAOK3 | 0.74443835 |
| 62 | TAOK2 | 0.74275273 |
| 63 | FGFR4 | 0.72603224 |
| 64 | LRRK2 | 0.71564374 |
| 65 | FYN | 0.68015774 |
| 66 | EPHA3 | 0.66967358 |
| 67 | RAF1 | 0.66712684 |
| 68 | ITK | 0.66256169 |
| 69 | ACVR1B | 0.65513630 |
| 70 | TEC | 0.64883365 |
| 71 | BMPR2 | 0.64582172 |
| 72 | PRKD2 | 0.62849130 |
| 73 | IKBKB | 0.58006262 |
| 74 | STK38 | 0.57622034 |
| 75 | WNK1 | 0.56353275 |
| 76 | MAPK7 | 0.55727015 |
| 77 | MAPK12 | 0.55205404 |
| 78 | MAP2K4 | 0.55123814 |
| 79 | STK11 | 0.53781560 |
| 80 | TGFBR2 | 0.50744072 |
| 81 | NEK9 | 0.46476017 |
| 82 | SGK3 | 0.45758915 |
| 83 | MAP2K6 | 0.42901596 |
| 84 | TRIB3 | 0.42335545 |
| 85 | MAP3K5 | 0.42243462 |
| 86 | RET | 0.41476151 |
| 87 | MAPKAPK2 | 0.38597142 |
| 88 | GRK7 | 0.38572267 |
| 89 | HIPK2 | 0.38376236 |
| 90 | RPS6KL1 | 0.37949530 |
| 91 | RPS6KC1 | 0.37949530 |
| 92 | SIK2 | 0.36882131 |
| 93 | PRKCQ | 0.36770982 |
| 94 | RPS6KA6 | 0.34614781 |
| 95 | PRKCZ | 0.33886521 |
| 96 | SGK2 | 0.32652435 |
| 97 | KSR1 | 0.30591982 |
| 98 | PRKAA2 | 0.25522060 |
| 99 | FRK | 0.24609167 |
| 100 | PRKD1 | 0.24546651 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.97570593 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 2.95565755 |
| 3 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.88947363 |
| 4 | Tuberculosis_Homo sapiens_hsa05152 | 2.14349456 |
| 5 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.07576708 |
| 6 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 2.06346723 |
| 7 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.05181168 |
| 8 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.02677614 |
| 9 | Malaria_Homo sapiens_hsa05144 | 1.96698839 |
| 10 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.95468598 |
| 11 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.91320172 |
| 12 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.89572443 |
| 13 | Allograft rejection_Homo sapiens_hsa05330 | 1.84007032 |
| 14 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.72889828 |
| 15 | Measles_Homo sapiens_hsa05162 | 1.71242305 |
| 16 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.67652219 |
| 17 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.63950076 |
| 18 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.63641917 |
| 19 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.54237033 |
| 20 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.53940868 |
| 21 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.53098482 |
| 22 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.51228504 |
| 23 | Influenza A_Homo sapiens_hsa05164 | 1.50033913 |
| 24 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.49065176 |
| 25 | Legionellosis_Homo sapiens_hsa05134 | 1.47182505 |
| 26 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.37973250 |
| 27 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.35603798 |
| 28 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.35263305 |
| 29 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.33573129 |
| 30 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.31352337 |
| 31 | Viral myocarditis_Homo sapiens_hsa05416 | 1.31026408 |
| 32 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.30287933 |
| 33 | Phagosome_Homo sapiens_hsa04145 | 1.26347294 |
| 34 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.26080051 |
| 35 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.24802978 |
| 36 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.24182956 |
| 37 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.22806035 |
| 38 | Platelet activation_Homo sapiens_hsa04611 | 1.22461502 |
| 39 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.20934379 |
| 40 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.18002388 |
| 41 | Hepatitis C_Homo sapiens_hsa05160 | 1.12352828 |
| 42 | Other glycan degradation_Homo sapiens_hsa00511 | 1.11534606 |
| 43 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.09346651 |
| 44 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.05874524 |
| 45 | Pertussis_Homo sapiens_hsa05133 | 1.05301946 |
| 46 | Hepatitis B_Homo sapiens_hsa05161 | 1.04866328 |
| 47 | Salmonella infection_Homo sapiens_hsa05132 | 1.01559263 |
| 48 | Galactose metabolism_Homo sapiens_hsa00052 | 1.00574218 |
| 49 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.00166680 |
| 50 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.98816421 |
| 51 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.90226642 |
| 52 | Amoebiasis_Homo sapiens_hsa05146 | 0.88544924 |
| 53 | Shigellosis_Homo sapiens_hsa05131 | 0.86197782 |
| 54 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.85211746 |
| 55 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.84768098 |
| 56 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.84451054 |
| 57 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.82540304 |
| 58 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.82285856 |
| 59 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.81727460 |
| 60 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.81415155 |
| 61 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.80133154 |
| 62 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.79442041 |
| 63 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.78792023 |
| 64 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.77158253 |
| 65 | Asthma_Homo sapiens_hsa05310 | 0.76728872 |
| 66 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.75832025 |
| 67 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.74061808 |
| 68 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.72366098 |
| 69 | Lysosome_Homo sapiens_hsa04142 | 0.72330225 |
| 70 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.72251324 |
| 71 | Apoptosis_Homo sapiens_hsa04210 | 0.71609705 |
| 72 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.71546448 |
| 73 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.70557055 |
| 74 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.70526465 |
| 75 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.69157416 |
| 76 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.68987176 |
| 77 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.68707973 |
| 78 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.67087600 |
| 79 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.66695993 |
| 80 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.65634646 |
| 81 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.65405506 |
| 82 | Endocytosis_Homo sapiens_hsa04144 | 0.63139809 |
| 83 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.62686013 |
| 84 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.58123604 |
| 85 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.57959665 |
| 86 | Insulin resistance_Homo sapiens_hsa04931 | 0.54775984 |
| 87 | Mineral absorption_Homo sapiens_hsa04978 | 0.53693862 |
| 88 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.52295511 |
| 89 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.50185219 |
| 90 | Endometrial cancer_Homo sapiens_hsa05213 | 0.49147623 |
| 91 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.47285939 |
| 92 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.46689864 |
| 93 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.45035776 |
| 94 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.44666855 |
| 95 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.44533351 |
| 96 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.41146792 |
| 97 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.40313829 |
| 98 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.39473768 |
| 99 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.39424579 |
| 100 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.36214328 |

